Abstract:Objective To investigate the effects of seizure frequency, antiepileptic monotherapy/combination therapy, and perimenstrual epilepsy on serum sex hormone levels in women with epilepsy.Methods Eighty-seven women with epilepsy were included in the study and grouped according to seizure frequency, monotherapy or combination therapy, and presence or absence of perimenstrual epilepsy. Serum levels of prolactin (PRL), estradiol (E2), progesterone (P), and testosterone (T) were determined and compared between the groups.Results The rate of elevation of PRL level and age of onset in the high-seizure frequency group were significantly higher than those in the low-seizure frequency group and control group (P<0.05), and the rate of decline of P level in the high-seizure frequency group was significantly higher than that in the low-seizure frequency group (P<0.05). The combination therapy group had a significantly higher rate of elevation of T level than the monotherapy group (P<0.05). Compared with the non-perimenstrual epilepsy group, the perimenstrual epilepsy group had significantly higher rate of elevation of PRL level, rate of decline of P level, and E2/P ratio (P<0.05 for all).Conclusions Elevated PRL level is associated with recent seizures. The decline of P level is associated with the severity of seizure. The levels of sex hormones are influenced by antiepileptic drugs, especially combination therapy with sodium valproate that has a marked impact on T level. P level and E2/P ratio are closely related to perimenstrual epilepsy, and P replacement therapy may be an effective way to treat perimenstrual epilepsy.